REDWOOD CITY, Calif., April 25 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced that the company will host a conference call and webcast on Tuesday, May 2, 2006 at 4:30 p.m. Eastern Time to discuss its first quarter financial results. The call and webcast will follow the release of the first quarter financial results after market close.
To access the live conference call via phone, please dial 877-356-8064 from the United States and Canada or 706-758-4314 internationally. The conference ID is 8371451. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through May 9 and may be accessed by dialing 800-642-1687 from the United States and Canada or 706-645-9291 internationally. The replay passcode is 8371451.
Additionally, you may access the live and subsequently archived webcast of the conference call from the Investor Relations section of the Company’s website at http://investor.genomichealth.com. Please connect to the web site at least 15 minutes prior to the call to allow for any software download that may be necessary. An archived replay of the call will be available until the next quarterly call.
About Genomic Health
Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(TM), which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit www.genomichealth.com.
Genomic Health, Inc.
CONTACT: Brad Cole of Genomic Health, Inc., +1-650-569-2281, orinvestors@genomichealth.com; or media, Emily Faucette of WeissCommPartners, +1-415-946-1066, or media@genomichealth.com
Web site: http://www.genomichealth.com//
